- Home
- HTLD vs KROS Comparison
HTLD vs KROS Comparison
Compare HTLD & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HTLD | KROS |
|---|---|---|
| Founded | 1978 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 683.1M | 655.9M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | HTLD | KROS |
|---|---|---|
| Price | $10.39 | $19.50 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 12 |
| Target Price | $9.25 | ★ $22.20 |
| AVG Volume (30 Days) | ★ 595.4K | 520.0K |
| Earning Date | 01-28-2026 | 02-25-2026 |
| Dividend Yield | ★ 0.77% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.57 |
| Revenue | ★ $868,930,000.00 | $246,718,000.00 |
| Revenue This Year | N/A | $6,924.79 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.38 |
| Revenue Growth | N/A | ★ 37798.31 |
| 52 Week Low | $7.00 | $9.12 |
| 52 Week High | $12.19 | $22.55 |
Technical Indicators
Market Signals| Indicator | HTLD | KROS |
|---|---|---|
| Relative Strength Index (RSI) | 73.37 | 50.97 |
| Support Level | $10.05 | $18.48 |
| Resistance Level | $10.54 | $19.67 |
| Average True Range (ATR) | 0.28 | 0.75 |
| MACD | 0.06 | -0.16 |
| Stochastic Oscillator | 97.55 | 49.87 |
Price Performance
Historical ComparisonAbout HTLD Heartland Express Inc.
Heartland Express Inc is engaged in providing truckload services across the United States, Mexico, and Canada. These truckload services are asset-based transportation services in the dry van truckload market. The company offers truckload temperature-controlled transportation services, and Mexico logistics services. A majority of its customers represent the consumer goods, appliances, food products, and automotive industries.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.